文献速递消化系统肿瘤

肝细胞核因子4γ在胃癌中的表达及其在细胞增殖和干性维持中的作用

[Expression of hepatocyte nuclear factor 4γ in gastric carcinoma and its role in cell proliferation and stemness].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2021-01-01

该研究检测了郑州大学第一附属医院2012至2015年胃癌根治术患者的102例石蜡组织和42例新鲜组织中HNF4γ的表达,发现胃癌组织HNF4γ表达高于癌旁正常组织,且与不良预后相关;体外实验显示HNF4γ过表达促进胃癌细胞增殖和干性并上调CD44,沉默则相反。

要点

  • 胃癌组织HNF4γ mRNA和蛋白表达均高于癌旁正常组织。
  • HNF4γ蛋白高表达与胃癌患者较差的中位生存和3年生存率相关。
  • HNF4γ过表达促进胃癌细胞增殖和干性,沉默则抑制,并伴随CD44表达变化。

核心结论

  • HNF4γ在胃癌组织中异常高表达,与胃癌患者的不良预后有关。
  • HNF4γ可促进胃癌细胞的增殖,并通过促进CD44的表达维持胃癌细胞的干性。

研究设计与样本

  • 收集2012至2015年郑州大学第一附属医院行胃癌根治术患者的胃癌及相应癌旁正常组织蜡块102例、新鲜组织42例。
  • 采用实时荧光定量聚合酶链反应、逆转录聚合酶链反应和免疫组化法检测HNF4γ表达。
  • 建立HNF4γ过表达胃癌细胞株AGS-HNF4γ和HNF4γ沉默细胞株HGC27-shHNF4γ,采用XTT细胞增殖、平板克隆实验、干细胞成球实验测定对增殖和干性的影响,Western blot检测CD44表达。

主要发现

  • 42例新鲜胃癌组织中HNF4γ mRNA表达水平为12.43±2.702,高于相应癌旁正常组织的3.639±1.109(P<0.010)。
  • 102例石蜡包埋胃癌组织中41.2%(42/102)HNF4γ蛋白表达阳性,高于癌旁正常组织的8.8%(9/102,P<0.001)。
  • HNF4γ蛋白表达与胃癌患者的分化程度、浸润深度、临床分期和淋巴结转移有关(均P<0.05)。
  • HNF4γ蛋白高表达组患者中位生存时间为25个月、3年生存率为4.8%(2/42),HNF4γ蛋白正常表达组中位生存时间为38个月、3年生存率为51.7%(31/60),差异均有统计学意义(均P<0.001)。
  • AGS-HNF4γ细胞克隆数为(243.5±24.5)个、成球率为(83.5±3.9)%,分别高于AGS-Vector细胞的(81.0±16.0)个和(21.8±5.6)%(P=0.030和P=0.010);HGC27-shHNF4细胞克隆数为(26.0±1.0)个、成球率为(20.8±8.4)%,低于HGC27-Vector细胞的(83.5±4.5)个和(72.5±4.8)%(P=0.006和P=0.030)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the role and molecular mechanism of hepatocyte nuclear factor 4γ (HNF4γ) in proliferation and stemness of gastric cancer. Methods: A total of 102 cases of paraffin-embedded gastric cancer tissues and matched adjacent gastric tissues and 42 cases of fresh-frozen tissues derived from gastric patients who received radical gastrectomy were collected from the First Affiliated Hospital of Zhengzhou University between 2012 to 2015. The expression of HNF4γ was tested by immunohistochemical staining, quantitative real-time polymerase chain reaction (qRT-PCR). HNF4γ overexpressed (AGS-HNF4γ) and shRNA silenced (HGC27-shHNF4γ) gastric cell lines were established. The effects of HNF4γ on cell proliferation and stemness were verified by XTT, clone formation and sphere formation assay. The expression of CD44 was detected by western blot. Results: The mRNA expression level of HNF4γ in fresh-frozen gastric cancer tissue was (12.43±2.702), which was significantly higher than (3.639±1.109) in normal tissue (P<0.001). The high protein expression rate of HNF4γ in paraffin-embedded gastric cancer tissues was 41.2% (42/102), which was significantly higher than 8.8% (9/102) in normal gastric mucosa tissue (P< 0.001). The protein expression of HNF4γ was closely related to the tumor differentiation, infiltration depth, lymph node metastasis and tumor stage (P<0.05). The median survival interval of patients with HNF4γ high expression was 25 months, the 3-year survival rate was 4.8% (2/42), significantly lower than 38 months and 51.7% (31/60) of patients with normal HNF4γ expression (P<0.001). The proliferation and CD44 protein expression of AGS-HNF4γ cells were significantly higher than those of the AGS-Vector cells. The number of clone formation, sphere formation rate of AGS-HNF4γ cells were 243.5±24.5 and (83.5±3.9)%, significantly higher than 81.0±16.0 and (21.8±5.6)% of AGS-Vector cells (P=0.030 and P=0.010, respectively). The proliferation and CD44 protein expression of HGC27-shHNF4 cells were significantly lower than those of the HGC27-vector cells. The number of clone formation, sphere formation rate of HGC27-shHNF4 cells were 26.0±1.0 and (20.8±8.4)%, significantly higher than 83.5±4.5 and (72.5±4.8)% of HGC27-vector cells (P=0.006 and P=0.030, respectively). Conclusions: HNF4γ is upregulated in the gastric cancer tissues and related with the poor prognosis of patients with gastric cancer. Overexpression of HNF4γ promotes the proliferation and remains the stemness of gastric cancer cells by upregulating the expression of CD44. 目的: 探讨肝细胞核因子4γ(HNF4γ)在胃癌细胞增殖和干性维持中的作用及机制。 方法: 收集2012—2015年在郑州大学第一附属医院行胃癌根治术患者的胃癌及相应癌旁正常组织蜡块102例,新鲜组织42例。分别采用实时荧光定量聚合酶链反应、逆转录聚合酶链反应和免疫组化法检测HNF4γ的表达情况。建立HNF4γ过表达胃癌细胞株AGS-HNF4γ和HNF4γ沉默细胞株HGC27-shHNF4γ,分别采用XTT细胞增殖、平板克隆实验、干细胞成球实验测定HNF4γ过表达和沉默对胃癌细胞增殖和干性的影响,Western blot检测CD44的表达。 结果: 42例新鲜胃癌组织中,HNF4γ mRNA的表达水平为12.43±2.702,高于相应癌旁正常组织3.639±1.109(P<0.010)。102例石蜡包埋胃癌组织中,41.2%(42/102)HNF4γ蛋白表达阳性,高于癌旁正常组织的8.8%(9/102,P<0.001)。HNF4γ蛋白表达与胃癌患者的分化程度、浸润深度、临床分期和淋巴结转有关(均P<0.05)。HNF4γ蛋白高表达组患者的中位生存时间为25个月,3年生存率为4.8%(2/42),HNF4γ蛋白正常表达组患者的中位生存时间为38个月,3年生存率为51.7%(31/60),差异均有统计学意义(均P<0.001)。AGS-HNF4γ细胞增殖快于对照AGS-Vector细胞,细胞克隆数高于AGS-Vector细胞[分别为(243.5±24.5)个和(81.0±16.0)个,P=0.030],细胞成球率高于AGS-Vector细胞[分别为(83.5±3.9)%和(21.8±5.6)%,P=0.010],CD44的表达量高于AGS-Vector细胞。HGC27-shHNF4细胞增殖慢于对照HGC27-Vector细胞,细胞克隆数低于HGC27-Vector细胞[分别为(26.0±1.0)个和(83.5±4.5)个,P=0.006],细胞成球率低于HGC27-Vector细胞[分别为(20.8±8.4)%和(72.5±4.8)%,P=0.030],CD44的表达量低于HGC27-Vector细胞。 结论: HNF4γ在胃癌组织中异常高表达,与胃癌患者的不良预后有关。HNF4γ可促进胃癌细胞的增殖,并通过促进CD44的表达维持胃癌细胞的干性。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jia YX, Tang H, Chang ZW, et al. [Expression of hepatocyte nuclear factor 4γ in gastric carcinoma and its role in cell proliferation and stemness]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34794218. doi:10.3760/cma.j.cn112152-20190725-00467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。